Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for reducing the immunogenicity of antibody variable domains

Method for reducing the immunogenicity of antibody variable domains

US Patent 6797492 · Granted Sep 28, 2004

Estimated economic value: $56,324,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Humanized pertussis antibodies and used thereof2020
Antibodies directed to membrane transporter NaP12b (SLC34A2) and uses thereof in2019
Humanized pertussis antibodies and uses thereof2018
Membrane transporter NaPi2b (SCL34A2) epitope for antibody therapy, antibodies d2017
Humanized pertussis antibodies and uses thereof2016
Isometheptene isomer2016
Specific binding proteins and uses thereof2015
Membrane transporter NaPi2b (SCL34A2) epitope antibodies2015
Humanized anti-tag 72 CC49 for diagnosis and therapy of human tumors2014
Framework residue substituted humanized COL-1 antibodies and their use2014
Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies d2013
Methods to determine immunogenicity of humanized anti-tag 72 CC49 antibodies2013